Intra-Cellular Therapies to Host Third Quarter 2021 Financial Results Conference Call and Webcast
Rhea-AI Summary
Intra-Cellular Therapies, Inc. (Nasdaq: ITCI) will host a conference call on November 9, 2021, at 8:30 a.m. ET to discuss its financial results for Q3 2021 and provide a corporate update. Investors can access the call via phone or through a live webcast available on the company’s investor relations website. Intra-Cellular Therapies focuses on developing treatments for central nervous system disorders using innovative, research-backed methods.
Positive
- Scheduled conference call for Q3 financial results indicates transparency and engagement with investors.
Negative
- None.
Insights
Analyzing...
NEW YORK, Nov. 02, 2021 (GLOBE NEWSWIRE) -- Intra-Cellular Therapies, Inc. (Nasdaq: ITCI), a biopharmaceutical company focused on the development and commercialization of therapeutics for central nervous system (CNS) disorders, today announced that it will host a conference call and live webcast discussion at 8:30 a.m. Eastern Time on Tuesday, November 9, 2021, to provide a corporate update and discuss details of the Company's financial results for the quarter ended September 30, 2021.
To access the live conference call via phone, dial 1-(844) 835-6563. The international dial-in number is 1-(970) 315-3916. The conference ID number for the live call is 3650108.
The live and archived webcast can be accessed under "Events & Presentations" in the Investor Relations section of the Company's website at www.intracellulartherapies.com. Please log in approximately 5-10 minutes prior to the event to register and to download and install any necessary software.
About Intra-Cellular Therapies
Intra-Cellular Therapies is a biopharmaceutical company founded on Nobel prize-winning research that allows us to understand how therapies affect the inner-workings of cells in the body. The company leverages this intracellular approach to develop innovative treatments for people living with complex psychiatric and neurologic diseases.
Contact:
Intra-Cellular Therapies, Inc.
Juan Sanchez, M.D.
Vice President, Corporate Communications and Investor Relations
646-440-9333
Burns McClellan, Inc.
Lisa Burns
cradinovic@burnsmc.com
212-213-0006
Source: Intra-Cellular Therapies Inc.
FAQ
When will Intra-Cellular Therapies announce its Q3 2021 financial results?
How can I listen to the Intra-Cellular Therapies conference call?
What is Intra-Cellular Therapies focused on?
